Clinical Trial Update: Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells

View source ↗

Summary

A clinical trial comparing ketorolac tromethamine 0.4% to prednisolone acetate 1% for reducing postoperative anterior chamber inflammation after selective laser…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Ketorolac tromethamine 0.4% (ketorolac tromethamine)
• Prednisolone Acetate 1% (prednisolone acetate)

Snippet

Sponsor: University of Pittsburgh | Conditions: Postoperative Complications, Inflammation | Status: TERMINATED